Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
News | Venous Therapies | February 22, 2021
February 22, 2021 — The U.S. Food and Drug Administration (FDA) recently cleared the Cook Medical Zilver Vena Venous...
A comparison showing angiography and optical coherence tomography (OCT) views of an undilated mid right coronary artery calcified lesion, post dilation with the Shockwave intravascular lithotripsy system, and the final result after stenting. The technology allows calcified lesions to be broken up without the need for vessel trauma caused by high pressure balloons or atherectomy.
Feature | Balloon Catheter | February 17, 2021
February 17, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Shockwave Medical's Intravascular...
SpectraWave is developing a a new intravascular imaging system that combines two currently available modalities. This likely includes optical coherence tomography (OCT), left, which can define structures within the vessel and vessel wall. Near infrared spectroscopy (NIRS), right, enables a spectral chemical analysis of the vessel walls to show areas of high lipid content, and specifically can identify lipid-core plaques that are associated with heart attack-causing plaque ruptures.
News | Cath Lab | February 16, 2021
February 16, 2021 – SpectraWave Inc. announced a $13.2 million series A-2 financing to support completion of product...
Feature | February 12, 2021
Diagnostic and Interventional Cardiology (DAIC) magazine maintains more than 50 comparison charts of product...
InspireMD's MicroNet embolic protection mesh on stents is designed to prevent emboli during carotid stenting.
News | Embolic Protection Devices | February 09, 2021
February 9, 2021 — InspireMD Inc., developer of the CGuard Embolic Prevention System (EPS) for the prevention of stroke...
The EndoWays disposable robotic system for cath lab procedural navigation.
News | Robotic Systems | February 09, 2021
February 9, 2021 — EndoWays, developer of a disposable robotic system for the cath lab, announced the completion of an...
News | Hemostasis Management | February 08, 2021
February 8, 2021 — Teleflex Inc. said it recently completed its acquisition of Z-Medica LLC, an industry-leading...
Videos | Cath Lab | February 04, 2021
Cindy Grines, M.D., MSCAI, FACC, president of the Society for Cardiovascular Angiography and Interventions (SCAI), and...
News | Heart Valve Technology | February 04, 2021
February 4, 2021 — Transcatheter aortic valve replacement (TAVR) has historically only been used with caution in the...
An interventional radiologist consults with a patient in an out patient cath lab at a Modern Vascular clinic. The company is building several out patient clinics to capture a share of the interventional market for peripheral artery disease (PAD) catheter-based therapies.
News | Cardiovascular Business | February 03, 2021
February 3, 2021 — Modern Vascular is a medical group that has 13 outpatient cath lab clinics to treat peripheral...
The Occlutech implantable Atrial Flow Regulator (AFR) maintains an interatrial shunt with a predetermined diameter allowing for controlled blood flow from the left to the right atrium enabling the left atrium to decompress and lower left atrial pressure. This reduced left atrial pressure reduces heart failure symptoms and improves exercise tolerance.
News | Heart Failure | January 27, 2021
January, 27, 2021 — The U.S. Food and Drug Administration (FDA) has granted Occlutech a Breakthrough Device designation...
The Pedra Blood Perfusion Index tracks real-time changes in foot tissue perfusion attendant with balloon inflation and deflation during an angioplasty procedure.
News | Peripheral Artery Disease (PAD) | January 26, 2021
January 26, 2021 — Pedra Technology, a privately held company, announced today that the U.S. Food and Drug...
News | Stents Drug Eluting | January 26, 2021
January 26, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Boston Scientific's Synergy Megatron Drug-...
An example of 3-D computer aided design (CAD) software from Materialise being used at Henry Ford Hospital to evaluate left ventricular outflow tract (LVOT) obstruction from a Sapian TAVR valve virtually implanted in the mitral valve position. Henry Ford uses both 3-D printing and CAD to plan and guide complex structural heart procedures.
Feature | Medical 3-D Printing | January 24, 2021 | By Dave Fornell, Editor
With increasing complexity of interventional structural heart disease and congenital heart disease interventions, 3-D...
News | Heart Valve Technology | January 20, 2021
January 20, 2021 — The U.S. Centers for Medicare and Medicaid Services (CMS) revised its National Coverage...
